ABSTRACT
OBJECTIVE: Psychopharmacology remains the foundation of treatment for bipolar disorder, but medication adherence in this population is low (range 20-64%). We examined medication adherence in a multisite, comparative effectiveness study of lithium. METHOD: The Lithium Moderate Dose Use Study (LiTMUS) was a 6-month, six-site, randomized effectiveness trial of adjunctive moderate dose lithium therapy compared with optimized treatment in adult out-patients with bipolar I or II disorder (N=283). Medication adherence was measured at each study visit with the Tablet Routine Questionnaire. RESULTS: We found that 4.50% of participants reported missing at least 30% of their medications in the past week at baseline and non-adherence remained low throughout the trial (<7%). Poor medication adherence was associated with more manic symptoms and side-effects as well as lower lithium serum levels at mid- and post-treatment, but not with poor quality of life, overall severity of illness, or depressive symptoms. CONCLUSION: Participants in LiTMUS were highly adherent with taking their medications. The lack of association with possible predictors of adherence, such as depression and quality of life, could be explained by the limited variance or other factors as well as by not using an objective measure of adherence.
Subject(s)
Affect/drug effects , Bipolar Disorder , Depression , Lithium Compounds , Medication Adherence , Adult , Antidepressive Agents/administration & dosage , Antidepressive Agents/adverse effects , Antidepressive Agents/blood , Antimanic Agents/administration & dosage , Antimanic Agents/adverse effects , Antimanic Agents/blood , Bipolar Disorder/diagnosis , Bipolar Disorder/drug therapy , Bipolar Disorder/psychology , Comparative Effectiveness Research , Depression/drug therapy , Depression/etiology , Drug Monitoring/methods , Female , Humans , Lithium Compounds/administration & dosage , Lithium Compounds/adverse effects , Lithium Compounds/blood , Male , Psychiatric Status Rating Scales , Quality of Life , Risk Factors , Treatment OutcomeABSTRACT
OBJECTIVE: This study examined general medical illnesses and their association with clinical features of bipolar disorder. METHOD: Data were cross-sectional and derived from the Lithium Treatment - Moderate Dose Use Study (LiTMUS), which randomized symptomatic adults (n = 264 with available medical comorbidity scores) with bipolar disorder to moderate doses of lithium plus optimized treatment (OPT) or to OPT alone. Clinically significant high and low medical comorbidity burden were defined as a Cumulative Illness Rating Scale (CIRS) score ≥4 and <4 respectively. RESULTS: The baseline prevalence of significant medical comorbidity was 53% (n = 139). Patients with high medical burden were more likely to present in a major depressive episode (P = .04), meet criteria for obsessive-compulsive disorder (P = .02), and experience a greater number of lifetime mood episodes (P = 0.02). They were also more likely to be prescribed a greater number of psychotropic medications (P = .002). Sixty-nine per cent of the sample was overweight or obese as defined by body mass index (BMI), with African Americans representing the racial group with the highest proportion of stage II obesity (BMI ≥35; 31%, n = 14). CONCLUSION: The burden of comorbid medical illnesses was high in this generalizable sample of treatment-seeking patients and appears associated with worsened course of illness and psychotropic medication patterns.
Subject(s)
Asthma/epidemiology , Bipolar Disorder/epidemiology , Hyperlipidemias/epidemiology , Hypertension/epidemiology , Migraine Disorders/epidemiology , Obsessive-Compulsive Disorder/epidemiology , Overweight/epidemiology , Adolescent , Adult , Black or African American/statistics & numerical data , Aged , Asian/statistics & numerical data , Bipolar Disorder/drug therapy , Body Mass Index , Comorbidity , Female , Humans , Male , Metabolic Syndrome/epidemiology , Middle Aged , Multivariate Analysis , Obesity/epidemiology , Obesity/ethnology , Overweight/ethnology , Psychotropic Drugs/therapeutic use , White People/statistics & numerical data , Young AdultABSTRACT
OBJECTIVE: We examined the relationship between mood symptoms and episodes in patients with bipolar disorder and burden reported by their primary caregivers. METHOD: Data on subjective and objective burden reported by 500 primary caregivers for 500 patients with bipolar disorder participating in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) were collected using semistructured interviews. Patient data were collected prospectively over 1 year. The relationship between patient course and subsequent caregiver burden was examined. RESULTS: Episodes of patient depression, but not mood elevation, were associated with greater objective and subjective caregiver burden. Burden was associated with fewer patient days well over the previous year. Patient depression was associated with caregiver burden even after controlling for days well. CONCLUSION: Patient depression, after accounting for chronicity of symptoms, independently predicts caregiver burden. This study underscores the important impact of bipolar depression on those most closely involved with those whom it affects.
